Evidence-Based Treatment Planning in mCRC: The Key to Maximising Outcomes

Chairperson:

Dirk Arnold¹

Speakers:

Eric Van Cutsem,² Sharlene Gill³

1. Medical Director of the Hubertus Wald Tumor Center at the University Cancer Center, Hamburg, Germany
2. Professor of Internal Medicine, Head of Digestive Oncology, University Hospital Gathuisberg, Leuven, Belgium
3. Associate Professor of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada

Disclosure:

For speaker disclosures, see page 37.

Acknowledgements:

Writing assistance provided by Lynda McEvoy, ApotheCom Scope Medical.

Citation:

EMJ Oncol. 2013;1[1]:32-37. DOI/10.33590/emjoncol/10313164. https://doi.org/10.33590/emjoncol/10313164.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.